A carregar...
Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents
In the past three decades, a great interest has arisen in the use of immunoglobulins as therapeutic agents. In particular, since the approval of the first monoclonal antibody Rituximab for B cell malignancies, the progress in the antibody-related therapeutic agents has been incremental. Therapeutic...
Na minha lista:
| Publicado no: | Antibodies (Basel) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7768499/ https://ncbi.nlm.nih.gov/pubmed/33333967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antib9040070 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|